Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease

Systemic sclerosis (SSc) is a complex, multiorgan, autoimmune disease. Lung fibrosis occurs in ∼80% of patients with SSc; 25% to 30% develop progressive interstitial lung disease (ILD). The pathogenesis of fibrosis in SSc-associated ILD (SSc-ILD) involves cellular injury, activation/differentiation...

Descripción completa

Detalles Bibliográficos
Autores principales: Khanna, Dinesh, Tashkin, Donald P., Denton, Christopher P., Renzoni, Elisabetta A., Desai, Sujal R., Varga, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2020
Materias:
Concise Clinical Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068837/
https://www.ncbi.nlm.nih.gov/pubmed/31841044
http://dx.doi.org/10.1164/rccm.201903-0563CI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068837/
https://www.ncbi.nlm.nih.gov/pubmed/31841044
http://dx.doi.org/10.1164/rccm.201903-0563CI

Ejemplares similares